Streetbeat News

Revenues

EIC

Eagle Point Income (NYSE:EIC) reported Q2 earnings per share (EPS) of $0.44, a 10.2% decrease from $0.49 YoY. However, sales increased by 89.63% to $10.91 million from $5.76 million YoY.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 12:10 pm

FSTR

L.B. Foster has revised its FY24 net sales forecast to a range of $525M to $550M, down from the previous range of $525M to $560M. Adjusted EBITDA is now expected to be between $34M and $37M, with free cash flow expected to be breakeven. The revised guidance reflects the impact of a restructuring program.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 12:10 pm

ORCL

Oracle has opened its second public cloud region in Riyadh, Saudi Arabia, as part of a $1.5 billion investment to enhance the country's cloud capacity in line with Saudi Vision 2030. This expansion aims to support AI innovation and business resilience for Saudi organizations.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 12:09 pm

SGMO

Sangamo shares are trading higher after entering a license agreement with Genentech to develop genomic medicines for neurodegenerative diseases. Sangamo will receive $50 million upfront and is eligible for up to $1.9 billion in milestones.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 12:08 pm

FSTR

L.B. Foster is continuing its enterprise restructuring program to reduce costs and invest in growth platforms. The restructuring, expected to be completed in the second half of 2024, will impact approximately 40 salaried employees and is projected to save $4.5 million annually.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 12:07 pm

MARA

Marathon Digital reported winning 201 blocks in July, a 27% increase month-over-month. BTC production rose 17% month-over-month to 692 BTC. The company's BTC holdings increased to 20,818, with total cash and BTC valued at $1.6 billion as of July 31, 2024.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 12:07 pm

SGMO

Sangamo Therapeutics has entered into a license agreement with Genentech to develop intravenously administered genomic medicines for neurodegenerative diseases. Sangamo will receive $50 million in upfront license fees and is eligible for up to $1.9 billion in milestone payments.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 12:07 pm

TALK

Talkspace has announced its fiscal year 2024 revenue expectations to be between $185 million and $195 million, compared to the consensus estimate of $189.802 million. The company also projects an adjusted EBITDA of $4 million to $8 million.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 12:05 pm

SHIP

Seaenergy Maritime Holdings announced that for Q3, it expects its operating days to be fixed at an estimated Time Charter Equivalent (TCE) rate of approximately $27,243.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 12:05 pm

DXR

Daxor Corporation has been awarded a $1.9 million two-year contract from the U.S. Air Force to develop a next-generation point-of-care blood volume analyzer using novel fluorescent tracer and optical sensing technology.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 12:05 pm